Elevai Labs Inc. — Form D/A

Elevai Labs Inc. of NEWPORT BEACH, CA, a company, filed a Form D amendment with the SEC on 2021-12-10. The offering totals $2.0M, of which $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Hatem Abou-SayedDirectorSan Diego, CA
Yi GuoDirectorDAVIS, CA
Hatem Abou-SayedExecutive OfficerSan Diego, CA
Braeden LichtiDirectorHARVARD, MA
Braeden LichtiExecutive OfficerHARVARD, MA
Braeden LichtiPromoterHARVARD, MA
Graydon BenslerDirectorHARVARD, MA
Graydon BenslerExecutive OfficerHARVARD, MA
Crystal MuilenburgDirectorNewport Beach, CA
Julie DaleyDirectorNewport Beach, CA
Chris KraneissExecutive OfficerNewport Beach, CA
Jeffrey ParryDirectorNewport Beach, CA
Hatem (Tim) Abou-SayedDirectorNewport Beach, CA
Hatem (Tim) Abou-SayedExecutive OfficerNewport Beach, CA
Brenda BuechlerExecutive OfficerNewport Beach, CA
Jordan PlewsDirectorNewport Beach, CA
Jordan PlewsExecutive OfficerNewport Beach, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2023-09-22D$550K$250K
2023-09-11D/A$1.6M$464K
2023-05-31D/A$1.6M$324K
2023-04-27D$1.6M$294K
2023-03-17D$1.5M$750K
2022-11-01D/A$4.3M$3.0M
2022-07-28D$4.3M$2.1M
2021-10-14D/A$2.0M$732K
2021-10-01D$2.0M$732K
2021-10-01D$139K$139K

More